ReviewApplied biochemistry and biotechnology2026
Bioactive Compound-Integrated Metal Nanoparticles Promote Wound Repair in Diabetic Conditions: Evidence from an Animal Study.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A significant clinical challenge in diabetic wound healing was impaired healing dynamics, necessitating innovative therapeutic strategies. Naturally derived bioactive molecules like alkaloids, terpenoids, flavonoids and polyphenols had demonstrated antimicrobial, antioxidant, anti-inflammatory, angiogenic, and collagen-promoting activities, but their clinical application is limited by poor solubility, metabolic instability, and low bioavailability. Using metallic nanoparticles (gold, silver, zinc oxide and copper oxide) in nanotechnology offers a promising platform to overcome these barriers, serving both as therapeutic agents and as delivery vehicles that enhance stability, tissue penetration, and controlled release of bioactive compounds. Preclinical studies using rodent and large-animal diabetic wound models have provided mechanistic insights into the synergistic effects of bioactive compound-incorporated nanoformulations, showing improvements in angiogenesis, fibroblast proliferation, immune regulation, and oxidative stress modulation. This review consolidates recent advancements in nano-enabled bioactive formulations for diabetic wound healing, critically analyzes their mechanisms of action and physicochemical determinants, and highlights translational challenges and research gaps. Ultimately, the integration of phytochemicals with nanotechnology holds substantial promise for accelerating wound repair and advancing towards clinical application.
Indexed as
Identifiers
42390734What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.